Adaptations of Adipose Tissue Expandability in Gestation are Associated with Maternal Glucose Metabolism
Authors
Rojas-Rodriguez, RazielFaculty Advisor
Silvia Corvera, MDAcademic Program
Translational ScienceUMass Chan Affiliations
Program in Molecular MedicineDocument Type
Doctoral DissertationPublication Date
2019-07-17Keywords
Gestational diabetesadipose tissue
IGFBP5
PAPP-A
Cellular and Molecular Physiology
Endocrinology
Endocrinology, Diabetes, and Metabolism
Female Urogenital Diseases and Pregnancy Complications
Maternal and Child Health
Reproductive and Urinary Physiology
Metadata
Show full item recordAbstract
Pregnancy induces maternal metabolic adaptations including mild glucose intolerance and weight gain in order to support fetal development and lactation. Adipose tissue (AT) function in gestation is featured by reduced insulin sensitivity and fat mass accrual which partly accounts for the weight gain in pregnant women and adaptation of glucose metabolism. A common metabolic pregnancy complication is gestational diabetes mellitus (GDM), a disease characterized by impaired glucose tolerance with onset in gestation. However, the relationship between AT expandability and glucose metabolism in gestation is not well understood. The goal of this thesis was to investigate the adaptations of human AT expansion induced by pregnancy, how these changes are reflected in pregnancies complicated with GDM and characterize a mouse model to study the mechanisms underlying this disease. This dissertation illustrates that pregnancy promotes AT expandability by a signaling mechanism between placental pregnancy-associated plasma protein-A (PAPP-A) and AT- insulin-like growth factor binding protein-5 (IGFBP5). In addition, gravidas with GDM showed impaired AT expansion. Studies investigating the relationship between PAPP-A and glycemic state demonstrated that low levels of PAPP-A in the 1sttrimester are highly associated with the development of GDM. Moreover, PAPP-A knockout mice exhibit reduced insulin sensitivity and impaired AT growth exclusively in gestation. These results expand the knowledge of AT biology in gestation and have the potential to improve maternal care by proposing PAPP-A as an early biomarker and possible therapeutic for GDM. It also introduces a new mouse model to study the etiology of gestational diabetes.DOI
10.13028/8sqa-6q31Permanent Link to this Item
http://hdl.handle.net/20.500.14038/31269Rights
Licensed under a Creative Commons licenseDistribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/8sqa-6q31
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Licensed under a Creative Commons license